Jul. 28 at 4:48 AM
🌅 4:00am ET Watchlist — July 28, 2026
$GOSS – Plans to submit an NDA for seralutinib in pulmonary arterial hypertension in September after its FDA Pre-NDA meeting. The clearer filing path and reacquired worldwide rights improve the setup, but approval risk, convertible securities, and a potential reverse split remain important considerations.
$POLA – Secured an optional committed equity facility for up to
$25M in common-stock sales. The agreement provides fresh working capital for data-center power, drone charging, robotics, EV charging, and microgrid projects, while creating potential dilution and resale pressure if used.
$INLF – AH runner with no clear same-night confirmed company release. Momentum-first, ultra-low-float/post-RS setup following its recent 1-for-200 reverse split, with traders watching volume, liquidity, spreads, and renewed interest in its robotics and battery-equipment themes.
Potential multi-day runners:
$LVWR ✅
$DFNS ✅
